STOCKHOLM, Sweden, Jan. 14, 2005 (PRIMEZONE) -- Observer's CFO, Anders Lundmark, has accepted an offer to become CFO of Pharmacia Diagnostics.
Pharmacia Diagnostics is the world's leading company in allergy diagnostics and is headquartered in Uppsala, Sweden. The company has an annual turnover of approximately 220 milion Euro and the owners, since April 2004, are the London-based venture capital companies PPM Ventures and Triton Advisers.
Anders Lundmark, who has been CFO of Observer for four years, will leave Observer in June 2005 at the latest. The process of recruiting his successor has begun.
Observer AB (publ)
For further information, please contact:
Robert Lundberg, CEO, telephone: +46 8 507 410 10, E-mail: robert.lundberg@observergroup.com
Per Blixt, Senior VP, Corporate Communications, telephone: +46 70 549 28 08, or +46 8 507 410 12 E-Mail: per.blixt@observergroup.com
Anders Lundmark, CFO, telephone: +46 70 333 29 77, or +46 8 507 417 23 e-mail: anders.lundmark@observergroup.com
Observer is the world's leading company in media monitoring and communication evaluation. Observer's services enable the clients to identify relevant target groups, distribute information, monitor their coverage and evaluate their communication.
Observer AB is quoted on the Attract 40 section of Stockholmsborsen's O-list and has approximately 25,000 shareholders. The company has approximately 2,400 employees and a turnover of SEK 1,5 billion in 2003. Observer operates in the US, UK, Sweden, Canada, Germany, Norway, Finland, Denmark, Portugal, Ireland, Estonia, Latvia and Lithuania.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=63649&fn=wkr0001.pdf